Hepatoprotective effect of chewable tablet of Centella asiatica (L.) Urb extractin Wistar rats induced by high fat diets
Abstract
Gotukola or Centella asiatica (L.) Urban contains high flavonoids which well known as fatty liver protector. This study aimed to evaluate the hepatoprotective effect of chewable tablet of C. asiatica (L.) Urb extract (CTCE) in Wistar rats induced by high fat diets. Twenty-one Wistar male rats aged 8-12 weeks with body weight ranging from 100-150 g were used in this study. Rats were randomly divided into seven groups i.e. Group 1 as normal control, rats were given standard food, Group 2 as high fat diets control, rats were induced high fat diets (HFD),
Group 3 as positive control, rats were induced HFD and given simvastatin, Group 4 as placebo control, rats were induced HFD and given placebo, Group 5-7 as treatment group, rats were induced HFD and given CTCE at doses of 100, 200 and 300 mg/kg BW, respectively. The HFD induction was conducted for five weeks and
the CTCE was given for one week in the last week of the induction. At the end of the intervention, blood triglyceride levels and SGPT as well SGOT activities were examined. Analysis of variance (ANOVA) with confidence interval of 95% (p<0.05) was applied. The results showed that the HFD induction increased the serum triglyceride levels and SGPT activity. The serum triglyceride levels and SGPT activity of Group 2 were significantly higher than Group 1 (p<0.05). Furthermore, the simvastatin and CTCE administration reduced the serum triglyceride levels and SGPT activity. The serum triglyceride levels and SGPT activity of Group 3, 5, 6
and 7 were significantly lower than Group 2 and 4 (p<0.05). In addition, the serum triglyceride levels and SGPT activity of Group 5, 6 and 7 were significantly lower than Group 3 (p<0.05). In conclusion, CTCE can reduce the serum triglyceride levels and SGPT activity in Wistar rats induced by HFD.
References
Chan SMH, Selemidis S, Bozinovski S, Vlahos R. Pathobiological mechanisms underlying metabolic syndrome (MetS)in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic strategies. Pharmacol Ther 2019; 198:160–88.
https://doi.org/10.1016/j.pharmthera.2019.02.013
Fazel Y, Koenig AB, Sayiner M, Goodman ZD, Younossi ZM. Epidemiology and natural history of non-alcoholic fatty liver disease. Metabolism 2016; 65:1017–25.
https://doi.org/10.1016/j.metabol.2016.01.012
Chaves GV, de Souza DS, Pereira SE, Saboya CJ, Ferreira Peres WA. Association between non-alcoholic fatty liver disease and liver function/injury markers with metabolic syndrome components in class III obese individuals. Rev Assoc Med Bras 2012; 58:288–93.
https://doi.org/10.1590/S0104-42302012000300007
Lim HW & Bernstein DE. Risk factors for the development of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis, including genetics. Clin Liver Dis 2018; 22:39–57.
https:/doi.org/10.1016/j.cld.2017.08.008
Li, J, Zou B, Yeo YH, Feng Y, Xie X, Lee DH, et al. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2019; 4:389-98.
https://doi.org/10.1016/S2468-1253(19)30039-1
Younossi ZM. Non-alcoholic fatty liver disease–A global public health perspective. J Hepatol 2019; 70:531-44.
https://doi.org/10.1016/j.jhep.2018.10.033
Lefere S & Tacke F. Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism. JHEP Reports 2019; 1:30–43.
https://doi.org/10.1016/j.jhepr.2019.02.004
Nyambuya TM, Dludla PV, Mxinwa V, Nkambule BB. Obesity-induced inflammation and insulin resistance: a mini-review on T-cells. Metab Open 2019; 3:100015.
https://doi.org/10.1016/j.metop.2019.100015
Louala S, Benyahia-Mostefaoui A, Lamri-Senhadji M. Low carbohydrate caloric restriction diet prevents non alcoholic fatty liver disease development, improves pro/antioxidant status and nitric oxide bioavailability in obese rat. Arch Cardiovasc Dis. Suppl 2019; 11:e374.
Ezzat WM, Ragab S, Ismail NA, Elhosary YA, El Baky AMNEA, Farouk H,et al. Frequency of non-alcoholic fatty liver disease in overweight/obese children and adults: Clinical, sonographic picture and biochemical assessment. J Genet Eng Biotechnol 2012; 10:221-7.
https://doi.org/10.1016/j.jgeb.2012.05.006
Chen YY, Yeh MM. Non-alcoholic fatty liver disease: A review with clinical and pathological correlation. J Formos Med Assoc 2020; 120:68-77.
https://doi.org/10.1016/j.jfma.2020.07.006
Wong SK, Chin KY, Ahmad F, Ima-Nirwana S. Regulation of inflammatory response and oxidative stress by tocotrienol in a rat model of non-alcoholic fatty liver disease. J Funct Foods 2020; 74:104209.
https://doi.org/10.1016/j.jff.2020.104209
Sutardi S. Kandungan bahan aktif tanaman pegagan dan khasiatnya untuk meningkatkan sistem imun tubuh. J Penelit Pengemb Pertan 2017; 35:121.
Krishnan N, Muthukrishnan S. Effect of Nigella sativa seed extract on carbon tetrachloride-induced hepatotoxicity in rats. J Acute Med 2012; 2:107-13.
Rosyadi AI. Pengaruh pemberian tablet kunyah ekstrak etanol herba pegagan (Centella asiatica (L.) Urban) terhadap berat dan gambaran histopatologik limpa. [Skripsi]. Yogyakarta: Universitas Ahmad Dahlan, 2009.
Dewi RT & Maryani F. Antioxidant and α-glucosidase inhibitory compounds of Centella asiatica. Procedia Chem 2015; 17:147-52.
https://doi.org/10.1016/j.proche.2015.12.130
Akrom & Prasetyawan N. Tablet kunyah ekstrak etanol herba pegagan (Centella asiatica (L.), Urban) menurunkan kadar kreatinin tikus putih jantan (Rattus norvegicus L.) galur wistar yang diberi diet lemak tinggi. Pharmaciana 2016; 6:123-30.
Qiu M, Xiao F, Wang T, Piao S, Zhao W, Shao S, et al. Protective effect of Hedansanqi Tiaozhi Tang against non-alcoholic fatty liver disease in vitro and in vivo through activating Nrf2/HO-1 antioxidant signaling pathway. Phytomedicine 2020; 67:153140.
https://doi.org/10.1016/j.phymed.2019.153140
Van De Wier B, Koek GH, Bast A, Haenen GRMM. The potential of flavonoids in the treatment of non-alcoholic fatty liver disease. Crit Rev Food Sci Nutr 2017; 57:834-55.
https://doi.org/10.1080/10408398.2014.952399
Fan JG, Kim SU, Wong VWS. New trends on obesity and NAFLD in Asia. J Hepatol 2017; 67:862-73.
https://doi.org/10.1016/j.jhep.2017.06.003
López-Sánchez GN, Dóminguez-Pérez M, Uribe M, Chávez-Tapia NC, Nuño-Lámbarri N. Non-alcoholic fatty liver disease and microRNAs expression, how it affects the development and progression of the disease. Ann Hepatol 2020; pre proof.
https://doi.org/10.1016/j.aohep.2020.04.012
Alexander-Aguilera A, Aguirre-Maldonado I, Antolin JR, Toledo LN, Rodriguez IS, Otero GS. Effect of Litchi chinensis on adipose and hepatic tissues in rats with obesity and non-alcoholic fatty liver disease (NAFLD). J Saudi Soc Agric Sci 2091; 18:235-40.
https://doi.org/10.1016/j.jssas.2017.06.002
Cardoso AS, Gonzaga NC, Medeiros CCM, De Carvalho DF. Association of uric acid levels with components of metabolic syndrome and non-alcoholic fatty liver disease in overweight or obese children and adolescents. J Pediatr (Rio. J) 2013; 89:412-8.
https://doi.org/10.1016/j.jped.2012.12.008
Meeran, MFN, Goyal SN, Suchal K, Sharma C, Patil CR, Ojah SK. Pharmacological properties, molecular mechanisms, and pharmaceutical development of asiatic acid: A pentacyclic triterpenoid of therapeutic promise. Front Pharmacol 2018; 9:892.
https://doi.org/10.3389/fphar.2018.00892
Bhattacharya RD, Parmar KM, Itankar PR, Prasad SK. Phytochemical and pharmacological evaluation of organic and non-organic cultivated nutritional Centella asiatica collected after different time intervals of harvesting. South African J Bot 2017; 112:237-45.
https://doi.org/10.1016/j.sajb.2017.06.003
Nie X, Zhang H, Shi X, Zhao J, Xhen S, Wu F, Yang J, Li X. Asiaticoside nitric oxide gel accelerates diabetic cutaneous ulcers healing by activating Wnt/β-catenin signaling pathway. Int Immunopharmacol 2020; 79:106109.
https://doi.org/10.1016/j.intimp.2019.106109
Subedi L, Timalsena S, Duwadi P, Thapa R, Paudel A, Parajuli K. Antioxidant activity and phenol and flavonoid contents of eight medicinal plants from Western Nepal. J Tradit Chinese Med 2014; 34:584-90.
